Shopping Cart - CHF 0.00

You have no items in your shopping cart.

  • Home  » 
  • 4008476
Return to Previous Page
4008476

Availability: In stock

α-MSH trifluoroacetate salt
Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH₂ trifluoroacetate salt

4008476

Product No. Pack Size Available ADS InfoAnalytical Data Sheet Unit Price Online Order Price Qty
4008476.0005 5 mg Ships within 1 business day ADSExemplary Data Sheet of a current available lot.
CHF 210.00
CHF 195.30 (7%)
4008476.0025 25 mg Ships within 1 business day ADSExemplary Data Sheet of a current available lot.
CHF 840.00
CHF 781.20 (7%)
Add to Wish List
Add to Compare

Details

α-Melanotropin, also known as α-melanocyte-stimulating hormone (α-MSH), is a 13-amino acid peptide originally characterized as a neuropeptide derived from the pituitary gland. α-MSH is synthesized from pro-opiomelanocortin (POMC) by the action of specific prohormone convertases and is involved in the regulation of important physiological functions including food intake, energy homeostasis, modulation of immune responses and photoprotection.
Catalog Number H-1075
APC Number 56-1-11
One Letter Code Ac-SYSMEHFRWGKPV-NH₂
Synonyms Acetyl-ACTH (1-13) amide, α-Melanotropin (human)
Molecular Formula C₇₇H₁₀₉N₂₁O₁₉S
Relative Molecular Mass 1664.91
CAS Registry Number [581-05-5] net
Source Synthetic
Storage Conditions -20 ± 5 °C
Areas of Interest Pituitary & Hypothalamic Hormones
Links / Documents:
Brochures:
No brochures found.

Bachem product citations

E.Raffan et al., Cell Metab., 23, 893 (2016)
N.Tennoune et al., Nutrition, 31, 498 (2015)
R.Cortes et al., Gen. Comp. Endocrinol., 201, 30 (2014)
G.S.Liu et al., Free Radic. Biol. Med., 70, 14 (2014)
A.I.Martin et al., Mediators Inflamm., 2014, 179368 (2014)
N.Tennoune et al., Transl. Psychiatry, 4, e458 (2014)
S.Veiksina et al., Biochim. Biophys. Acta, 1838, 372 (2014)
W.T.Weng et al., Biochim. Biophys. Acta, 1840, 1850 (2014)
J.M.Yoder et al., Am. J. Physiol. Regul. Integr. Comp. Physiol., 306, R837 (2014)
Q.Coquerel et al., Psychoneuroendocrinology, 37, 94 (2012)
H.R.Sobhi et al., J. Chromatogr. A., 1218, 8536 (2011)
D.Zegers et al., Obesity (Silver Spring), 19, 152 (2011)
M.W.Gardner and J.S.Brodbelt, Anal. Chem., 82, 5751 (2010)
N.Santoro et al., BMC Med. Genet., 10, 25 (2009)
N.Santoro et al., BMC Med. Genet., 10, 25 (2009)
M.Charnley et al., Peptides, 29, 1004 (2008)
M.W.Gardner et al., Anal. Chem., 80, 4807 (2008)
S.C.Harmer et al., J. Endocrinol., 196, 149 (2008)
D.Li and A.W.Taylor, J. Leukoc. Biol., 84, 191 (2008)
A.Nesterov et al., Chem. Pharm. Bull. (Tokyo), 56, 1292 (2008)
A.W.Taylor and N.Kitaichi, Brain Behav. Immun., 22, 639 (2008)
J.D.Spencer et al., J. Invest. Dermatol., 127, 411 (2007)
G.Cai et al., Obesity (Silver Spring), 14, 1596 (2006)
E.U.Do et al., Biochem. Biophys. Res. Commun., 343, 1094 (2006)
J.Menyhert et al., Brain Res., 1076, 101 (2006)
H.B.Schioth et al., Basic Clin. Pharmacol. Toxicol., 99, 287 (2006)
Z.Xiang et al., Biochemistry, 45, 7277 (2006)
L.Zvejniece et al., Pharmacol. Biochem. Behav., 85, 287 (2006)
R.L.Bradley et al., Obes. Res., 13, 653 (2005)
T.A.Czyzyk et al., Dev. Biol., 287, 301 (2005)
C.Lindberg et al., Neurotox. Res., 8, 267 (2005)
C.E.de Rijke et al., Biochem. Pharmacol., 70, 308 (2005)
Z.Marinova et al., Biochem. Biophys. Res. Commun., 321, 202 (2004)
I.S.Farooqi et al., N. Engl. J. Med., 348, 1085 (2003)
S.J.Getting et al., J. Pharmacol. Exp. Ther., 306, 631 (2003)
S.A.Stanley et al., FEBS Lett., 543, 66 (2003)
I.S.Farooqi et al., J. Clin. Invest., 106, 271 (2000)
M.Szardenings et al., Peptides, 21, 239 (2000)
P.K.Garg et al., Bioconjug. Chem., 7, 233 (1996)

4008476

Enzyme Substrates Inhibitors
Neurolysin    
Related products